The rise in the share price to $2 and above is normal and if it hadn't been for the skepticism in the American markets, Brainchip would have at least maintained this price.Why ?Because brainchip is a "game changer" and because a large international company (Mercedes) validated the product for the first time. Indeed they were the first to say that the chip worked in their finished product. And not just a little since it's 10 times more than their current "hey mercedes" technology. At this scale we can say that the old technology is completely obsolete. It is now obvious that Mercedes will integrate the brainchip chip in all its vehicles! And since Mercedes is a leader in the automotive industry, all other car manufacturers will be obliged to do the same, whether for entertainment or for road safety. And as the automotive industry is a major industry other industries will follow. Eventually (about 5 years) neuromorphic chips will invade our daily lives. there will then surely be other manufacturers but they will arrive after brainchip is already installed as a leader.That's why you have to keep.
- Forums
- ASX - By Stock
- BRN
- Why I have not sold all my shares
Why I have not sold all my shares, page-144
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online